ArticleJournal of clinical medicine2024
Immunosuppressive Induction Therapy Using the Antithymocyteglobulin Grafalon: A Single-Center Non-Interventional Study.
Nikolaus Becker, David Pereyra, Jule Dingfelder, Chiara Tortopis, Tina Saffarian Zadeh, Moriz Riha, Sertac Kacar, Thomas Soliman, Gabriela A Berlakovich, Georg Györi
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Nikolaus BeckerDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.
David PereyraDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.ORCID 0000-0001-6700-9163 Jule DingfelderDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.
Chiara TortopisDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.
Tina Saffarian ZadehDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.
Moriz RihaDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.
Sertac KacarDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.
Thomas SolimanDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.ORCID 0000-0001-6871-9343 Gabriela A BerlakovichDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.ORCID 0000-0001-8850-7874 Georg GyöriDepartment of General Surgery, Division of Transplantation, Medical University of Vienna, 1090 Wien, Austria.ORCID 0000-0002-0863-2876 Funding
Neovii Pharmaceuticals AG FA731E0609
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
ATGbiopsy-proven acute rejectionGrafalonimmunosuppressioninduction therapyliver transplantationreal-world evidencesafetyThymoglobulin
Identifiers
PMID39064090
PMCPMC11277975
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390